Auxilius Pharma S.A.

Manufacture of pharmaceutical preparations

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2025-04-03
Share capital
232,124.90 PLN
Activity description

Auxilius Pharma is an emerging pharmaceutical company focused on developing Value-Added Medicines for cardiovascular health, specifically targeting chronic stable angina. The company is introducing AUX-001, an effective angina symptom-controlling agent that is taken once daily and has shown to reduce hospitalization rates. AUX-001 utilizes the active ingredient nicorandil and aims to address both macro and microvascular angina.

Registered address
ul. Hoża 86/410, 00-682 Warszawa, Poland
Email
Social media
Electronic delivery address
AE:PL-96011-48563-JACRG-17

Financials

From the notes

Current income tax (CIT due)$0

Filing timeliness

1 of 1 financial statements was filed late (for 2025, 5 days late). All were audited by a statutory auditor.

  • 202520/07/2026
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Top 99%
Sector · Manufacturing24,217 / 24,570
Top 99%
City · Warszawa54,605 / 56,772
Top 96%
Voivodeship · Mazowieckie74,397 / 76,953
Top 97%
Country · Poland289,829 / 297,266
Top 98%

Results vs industry

Revenue
This companyUSD 0.83MedianUSD 913.43kAverageUSD 25.82m
Net profit
This companyUSD -355.74kMedianUSD 14.22kAverageUSD 2.77m
Operating costs
This companyUSD 273.22kMedianUSD 846.99kAverageUSD 21.42m
Assets
This companyUSD 5.74mMedianUSD 897.46kAverageUSD 31.52m

Offer

  • Cardiology medicines
  • Anti-anginal medicines
  • Modified-release nicorandil

Websites

Authorized Representatives

Jędrzej Litwiniuk age 46 – President of the Management Board

Manner of representation

The company is represented by one member of the management board in the case of a one-person management board, and by two members of the management board acting jointly or by a member of the management board together with a commercial proxy in the case of a multi-member management board.

Supervisory board

Mariusz Adamski age 40 – Supervisory Board Member
Przemysław Daniel Mazurek age 50 – Supervisory Board Member
Tomasz Hubert Zastawny age 63 – Supervisory Board Member
Jakub Tatak age 51 – Supervisory Board Member
Sławomir Kościak age 42 – Supervisory Board Member

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2020-03-30.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

PurposeGross amount
Aid for SME access to finance — risk finance aid
$896.9K

Change history

DateEvent
2025-09-23Share capital increase
2025-07-28Address change
2025-07-28Share capital increase
2025-04-03Entered in the register

FAQ

Last updated: 2026-11-05